Inversago Pharma
Inversago Pharma is a Canadian biotech company at clinical-stage, specializing in the development of new therapies focusing on CB1 blockade.
B2X
0
Country
Crunchbase URL
Founded Date
2016
0
Latest Funding Round Date
October 17, 2022
Latest Funding Round Amount (USD)
68,740,000
Latest Funding Type
LinkedIn URL
Location
Number of Employees (Ranges)
11 – 50
0
Pitchbook URL
Total Funding Amount (USD)
110,740,000
Official Website
Find more companies like Inversago Pharma
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.